Rx Importation May Be Price For Moving McClellan To CMS
This article was originally published in The Pink Sheet Daily
Executive Summary
Reimportation advocates are threatening to put a hold on the nomination of FDA Commissioner McClellan to head CMS. HHS' reimportation task force may be one part of a compromise.
You may also be interested in...
CMS Nominee McClellan Says He Will Testify On Rx Imports, But May Still Face Confirmation Delay
FDA Commissioner McClellan tells the Senate Finance Committee he will testify about drug reimportation after his nomination to head the Centers for Medicare & Medicaid Services is approved by the Senate. Sen. Dorgan, who has threatened to place a "hold" on the vote, is understood to be unwilling to wait.
CMS Nominee McClellan Says He Will Testify On Rx Imports, But May Still Face Confirmation Delay
FDA Commissioner McClellan tells the Senate Finance Committee he will testify about drug reimportation after his nomination to head the Centers for Medicare & Medicaid Services is approved by the Senate. Sen. Dorgan, who has threatened to place a "hold" on the vote, is understood to be unwilling to wait.
Reimportation Amendment Added To Senate FY 2005 Budget Resolution
Sen. Stabenow's amendment passes Budget Committee 14-8 with five GOP votes, including Grassley and Gregg. U.S. consumers would save $40 bil. over 10 years.